Search fresh public links, source activity, and ready-to-use post angles for Amgen.
Fresh curated links around Amgen are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Amgen generated $8.1 billion in free cash flow in 2025, with a 21% net margin, while Axsome is scaling rapidly but still unprofitable.
Amgen reached a $74 million settlement of a lawsuit accusing the biotechnology company of waiting too long to disclose that it might owe the Internal Revenue Service $10.7 billion...
Amgen has laid off around 40 employees as part of “organizational changes” meant to better align operations with the company’s strategic objectives, Fierce has learned.
Amgen has agreed to pay $74 million to resolve a shareholder class action in the Southern District of New York alleging the company waited too long to disclose a potential IRS tax...
Headquarters: US - California - Thousand Oaks URL: http://amgen.com Career CategoryMarketingJob DescriptionWhat you will doLet's do this. Let's change the world. At Amgen, ou...
Amgen has agreed to pay $74 million to resolve a shareholder class action in the Southern District of New York alleging the company waited too long to disclose a potential IRS tax...
Two forces now hitting pharma revenues, and both carry direct implications for employer health plans
Amgen is expanding its footprint in India with an R&D center in Hyderabad, the latest by from the California company to boost its research facilities.
Amgen Inc. experienced a cyber incident that involved the theft of patient information and proprietary data stored in cloud servers, it said in a filing July 31, the latest large h...
Spero Therapeutics enters immunology with an antibody licensed from Innovent Biologics. The lead indication is a rare autoimmune condition where Spero aims to offer advantages over...
Gillian R. Brassil (Bloomberg): Amgen Settles Investor Suit Over Tax Liability for $74 Million: Amgen Inc. agreed to cough up $74 million to resolve allegations that the pharmaceut...
ANC Anonymous (not verified) Tue, 08/04/2026 - 21:28 field_thread_url https://cafepharma.com/boards/threads/anc.712901/ board name...
Layoffs Anonymous (not verified) Mon, 07/20/2026 - 15:19 field_thread_url https://cafepharma.com/boards/threads/layoffs.716278/ board na...
Tezspire succeeded in a study in eosinophilic esophagitis, which could become the drug’s third approved indication and unlock what’s viewed as a blockbuster opportunity.
Layoffs Anonymous (not verified) Tue, 07/21/2026 - 15:20 field_thread_url https://cafepharma.com/boards/threads/layoffs.716278/ board na...
Pharmaceutical company Amgen says it suffered a data breach after threat actors stole corporate data and patient information stored in multiple cloud systems operated by third-part...
The Federal Trade Commission has urged the Fourth Circuit to reject Amgen's "sweeping" assertion that commercial agreements for acquiring the rights to patent applications are shie...
AstraZeneca and Amgen drug Tezspire met the goals of a Phase 3 test in eosinophilic esophagitis (EoE), a chronic disorder whose only approved biologic therapy is Sanofi’s Dupixent....
BioMarin Pharmaceutical has agreed to buy Alesta Therapeutics for $275 million upfront, positioning the biopharma to challenge AstraZeneca in the rare bone disease market.
Genmab Anonymous (not verified) Mon, 07/13/2026 - 12:14 field_thread_url https://cafepharma.com/boards/threads/genmab.680642/ board name...
Amgen has ended development of its early-stage obesity drug AMG 513, foisting its hopes for a slice of the massive weight loss market onto the shoulders of phase 3 candidate MariTi...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.